Future Directions and Unmet Needs in Relapsed/Refractory MCL

A panel of experts discuss future directions and remaining unmet needs for patients with relapsed/refractory MCL.

Related Keywords

,Recent Updates ,Follicular Lymphoma ,Mantle Cell Lymphoma ,Unmet Needs ,Cmcl ,Relapsed Refractory Mcl ,Relapsed Refractory Mantle Cell Lymphoma ,Triangle Trial ,Shine Trial ,Sympatico Trial ,Dbtk ,Bcl2 ,Ibrutinib ,Venetoclax ,